Bruce (Ned) Calonge, M.D., M.P.H. (Chair), is president and chief executive officer of The Colorado Trust, a private grant-making foundation dedicated to achieving health equity for all Coloradans. He is associate professor of family medicine at the Colorado School of Medicine, University of Colorado Denver, and associate professor of epidemiology at the Colorado School of Public Health. Nationally, he serves on the Centers for Disease Control and Prevention’s (CDC’s) Community Preventive Services Task Force. He also serves on the National Academies of Sciences, Engineering, and Medicine’s Board on Population Health and Public Health Practice, as well as on the Roundtable on the Promotion of Health Equity. In 2016, he participated on two National Academies committees, supporting the release of two publications: Communities in Action: Pathways to Health Equity and An Evidence Framework for Genetic Testing. Dr. Calonge is past chair of the U.S. Preventive Services Task Force, past chair of CDC’s Evaluating Genomic Applications in Practice and Prevention Working Group, past co-chair of the National Academies’ Genomics in Public Health Action Collaborative, and ongoing consultant for and past member of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dr. Calonge serves as a board member for Delta Dental of Colorado and is a board member and treasurer for the Colorado Association of Funders. Prior to coming to The Colorado Trust, he was chief medical officer of the Colorado Department of Public Health and Environment. He also served as chief of the Department of Preventive Medicine for the Colorado Permanente Medical Group and as a family physician for 10 years. He is past president of the Colorado Medical Board, the state physician-licensing board. Dr. Calonge received his B.A. in chemistry from The Colorado College, M.D. from the University of Colorado, and M.P.H. from the University of Washington. He was elected to the National Academy of Medicine in 2011.
David M. Abramson, Ph.D., M.P.H., is founding director of New York University’s (NYU’s) Program on Population Impact, Recovery and Resilience, faculty member of NYU’s School of Global Public Health, and associate faculty member of the NYU Grossman School of Medicine’s Department of Population Health. Prior to joining the NYU faculty in 2014,
Dr. Abramson was deputy director at Columbia University’s National Center for Disaster Preparedness at the Earth Institute. He has led a number of major research studies examining the long-term impacts of disasters on communities and on vulnerable populations, including children. These studies include the longitudinal Gulf Coast Child and Family Health study, post–Hurricane Katrina, which recently received funding from the National Institutes of Health (NIH) to look at recovery 10 years after the storm, and the Sandy Child and Family Health study, currently being conducted in partnership with Rutgers University with funding from the New Jersey Department of Health. Dr. Abramson is also co-investigator of the NIH-funded Women’s and Their Children’s Health study, exploring the impact of the Deepwater Horizon oil spill on children’s long-term health, in collaboration with Louisiana State University. Among his research-to-action initiatives, he is co-founder and co-director of the SHOREline youth empowerment project with Colorado State University’s Dr. Lori Peek, a curricular project-based learning program presently operating in a number of Gulf Coast and New York City high schools. In addition to disaster recovery work related to Hurricanes Katrina and Sandy and the Deepwater Horizon oil spill, he has studied short-term post-tornado community recovery in Joplin, Missouri; disaster recovery planning in four mid-sized U.S. cities; risk communication strategies; and organizational and attitudinal aspects of disaster preparedness. Dr. Abramson received his Ph.D. in sociomedical sciences from Columbia University, with a specialization in political science, and an M.P.H. from Columbia University. Over the past 25 years, he has conducted research on HIV/AIDS, public health systems, and civic engagement policy and practice. Prior to entering the field of public health, Dr. Abramson spent a decade as a national magazine journalist, having worked at or written for such publications as Rolling Stone, Esquire, and Outside magazines, among others.
Julie Casani, M.D., M.P.H., is medical director of Student Health Services at North Carolina State University, where she oversees the delivery of primary care, women’s services, physical therapy, nutrition services, and pharmacy to students, faculty, and staff. She is an adjunct associate professor in biological sciences, providing instruction in global public health, agriculture security, and One Health, and mentors prehealth students. Until June 2017, she was director of public health preparedness and response in the North Carolina Division of Public Health. This branch coordinates the preparedness system for 4 regional offices, as well as 85 local health departments for which it provides response and recovery coordination, subject-matter expertise, and support. From 1999 to 2006, Dr. Casani was preparedness director at the Maryland Department of Health and Mental Hygiene. She has been a policy and health practice consultant to several national workshops and committees on weapons of mass destruction for federal and state agencies, serving on three defense science boards. She also served three consecutive terms as a member of the Homeland Security Science and Technology Advisory Committee for the U.S. Department of Homeland Security. She recently co-authored the text Disasters and Public Health: Planning and Response. Dr. Casani practiced clinical emergency medicine in the Johns Hopkins system for 17 years. She has been actively involved in emergency medical services (EMS) since the 1970s, serving at every level from ambulance provider to an appointed member of the Maryland State EMS Board. Dr. Casani received her M.D. from the New York University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health.
David Eisenman, M.D., M.S.H.S., is professor in residence at the David Geffen School of Medicine and the Fielding School of Public Health at the University of California, Los Angeles (UCLA), where he is director of the Center for Public Health and Disasters. For more than 15 years, Dr. Eisenman has been funded by the National Institutes of Health,
the National Science Foundation, the Centers for Disease Control and Prevention, the U.S. Department of Homeland Security, and other federal agencies to conduct studies in the field of public health and disasters. He is a committee member for the National Health Security Preparedness Index and co-chairs the Social and Economic Standing Committee, National Institute of Standards and Technology Community Resilience Planning Guide for Buildings and Infrastructure Systems. From 2012 to 2016, Dr. Eisenman served as preparedness science officer for the Emergency Preparedness and Response Program at the Los Angeles County Department of Public Health. He is also an associate natural scientist at RAND Corporation, where he is a member of the Human Subjects Protection Committee. Dr. Eisenman is a credentialed physician for the Los Angeles County Emergency System, Advance Registration of Volunteer Health Professionals Program. He holds a board certification in internal medicine and cares for patients at the UCLA Medical Center.
Francisco García, M.D., M.P.H., is deputy county administrator and chief medical officer of Pima County in Tucson, Arizona. Located on the U.S.–Mexico border, Pima County is a large government jurisdiction the size of the state New Hampshire, with more than 1 million inhabitants. In that capacity he oversees the departments of Public Health, Behavioral Health, Animal Care Center, Medical Examiner, and Community & Workforce Development. Dr. García is former chair of the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Prevention Advisory Committee. He is a former member of the National Academies’ Roundtable on Health Equity and the Elimination of Health Disparities, as well as the Institute of Medicine Committee on Preventive Services for Women. He is also a past member of the U.S. Preventive Services Task Force. Prior to joining Pima County, Dr. García was a distinguished outreach professor of public health and obstetrics and gynecology, and served in a variety of leadership roles at the University of Arizona, including director of the Center of Excellence in Women’s Health, the Arizona Hispanic Center of Excellence, and the Cancer Disparities Institute of the Arizona Cancer Center.
Paul Halverson, Dr.P.H., is founding dean of the Indiana University Richard M. Fairbanks School of Public Health in Indianapolis. He came to Indiana University from the Arkansas Department of Health, where he served as state health officer and director. Prior to his appointment as state health officer, Dr. Halverson served in senior leadership roles at the Centers for Disease Control and Prevention (CDC), including as senior advisor in the Office of Strategy and Innovation, senior scientist and director of the Division of Public Health Systems Development and Research, director of CDC’s World Health Organization’s Collaborating Center for Public Health Practice, and director of the National Public Health Performance Standards program. Before joining CDC, he served as senior health policy advisor for the North Carolina Department of Environment, Health, and Natural Resources. Dr. Halverson began his career in health administration and has 15 years of experience as a hospital and health system executive, working in Michigan, Minneapolis, and Phoenix. He earned his doctorate in public health from the University of North Carolina, his master’s degree in health services administration from Arizona State University, and is a fellow of the American College of Healthcare Executives.
Sean Hennessy, Pharm.D., Ph.D., is professor of epidemiology in biostatistics at the University of Pennsylvania. He conducts research in the field of pharmacoepidemiology, which is the study of the health effects of drugs and other medical products in populations. His team identified a survival benefit of potassium supplementation in users of loop diuretics, and studied serious health consequences of drug–drug interactions involving high-risk drugs
including anticoagulants, antidiabetic agents, and antiplatelet agents. His research has produced crucial knowledge about the cardiovascular safety of many widely used drugs for mental health conditions, including attention deficit hyperactivity disorder, depression, and schizophrenia. Dr. Hennessy also evaluated an early approach to using medical insurance data to improve prescribing, finding it ineffective despite its federal mandate. This work contributed to the omission of a requirement for drug utilization review programs in Medicare Part D. Dr. Hennessy co-led a pair of studies demonstrating the effectiveness and safety of the SA14-14-2 vaccine for Japanese encephalitis (JE), which subsequently led to the immunization of millions of children annually in populous countries including Cambodia, India, Malaysia, Nepal, Sri Lanka, and Thailand. Use of that vaccine has been credited with reducing the incidence of JE. Dr. Hennessy co-developed the trend-in-trend research design for studying the effects of rapidly increasing or declining exposures. He was the senior author of one of two citizen petitions to the U.S. Food and Drug Administration that led to the relabeling of metformin, the best-proven oral drug for diabetes, to permit its use in persons with mild to moderate renal insufficiency.
Edbert Hsu, M.D., M.P.H., FACEP, joined the Department of Emergency Medicine faculty after completing an international emegency medicine fellowship at Johns Hopkins. Combining his international health background with a special interest in disaster medicine, he has worked on emergency medicine program development and public health preparedness around the world. Currently, he serves on the leadership group of the Office of Critical Event Preparedness and Response. Dr. Hsu has been a co-investigator with the U.S. Department of Homeland Security Center for the Study of Preparedness and Catastrophic Event Response at Johns Hopkins and is currently a co–principal investigator on a Centers for Disease Control and Prevention–sponsored project studying public health leadership training for crises. He has completed several systematic reviews supported by the Agency for Healthcare Research and Quality. In recent years, he has been interested in the topic of mass gatherings and crowd disasters. Dr. Hsu serves as associate editor for the American Medical Association journal Disaster Medicine and Public Health Preparedness. He holds an M.D. from the University of Pittsburgh School of Medicine and an M.P.H. from the Johns Hopkins Bloomberg School of Public Health.
Nathaniel Hupert, M.D., M.P.H., is an internal medicine physician and public health researcher focusing on health care operations research, with a special emphasis on public health emergencies and response logistics. He currently serves as associate attending physician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, where he is associate professor of health care policy and research and of medicine; in addition, since 2006 he has been co-director of the Cornell Institute for Disease and Disaster Preparedness. Using a variety of computational and data analytic methods, his research seeks to improve the effectiveness of care delivery in both conventional and crisis settings. Since September 2000, Dr. Hupert has collaborated with local, state, federal, and international public health officials in advancing clinical and health system preparedness for bioterrorism and other public health emergencies. Several of his computer models of mass antibiotic dispensing and hospital surge capacity have been widely downloaded and used by public health professionals worldwide. Dr. Hupert led the development of two U.S. health care planning documents: The Community Guide for Public Health Preparedness (2004) and the Guidebook for Hospital Preparedness Exercises (2010). He has served on the Anthrax Modeling Working Group of the U.S. Department of Health and Human Services (HHS) (2003–2009), was a member of the 2007 RAND Expert Panel on Defining Public Health Preparedness, was founding direc-
tor of the Preparedness Modeling Unit at the Centers for Disease Control and Prevention (CDC) (2008–2010), and served on the Scientific Advisory Board of the National Institutes of Health’s Modeling of Infectious Disease Agent Study (MIDAS) (2012–2014). Between 2011 and 2017, he served as medical advisor for CDC’s Division of Preparedness and Emerging Infections; he also held similar appointments at the HHS Biomedical Advanced Research and Development Authority (2014–2015) and the HHS National Healthcare Preparedness Program (2016). Dr. Hupert trained at the Harvard Medical School, the University of Pittsburgh Medical Center, and the Harvard T.H. Chan School of Public Health.
Rebecca A. Maynard, Ph.D., is professor of education and social policy at the University of Pennsylvania. She is a leading expert in the design and conduct of randomized controlled trials in the areas of education and social policy. She has conducted influential methodological research, including co-developing PowerUP! to support efficient sample designs for causal inference studies, and has been influential in advancing the development and application of research synthesis methods. In 2016, she stepped down from a 12-year tenure as director of the University of Pennsylvania’s Predoctoral Training Program in Interdisciplinary Methods for Field-based Education Research, which has served more than 75 Ph.D. students from arts and sciences, business, and education. From 2010 through 2012, Dr. Maynard served as commissioner of the National Center for Education Evaluation and Regional Assistance at the Institute of Education Sciences. In this role, she oversaw the Institute’s evaluation initiatives, the What Works Clearinghouse, the Regional Education Laboratories, and the National Library of Education (including ERIC). Prior to joining the faculty at the University of Pennsylvania in 1993, she was senior vice president at Mathematica Policy Research, Inc. Dr. Maynard holds a Ph.D. in economics from the University of Wisconsin–Madison.
Suzet McKinney, Dr.P.H., M.P.H., currently serves as chief executive officer and executive director of the Illinois Medical District, a 24/7/365 environment that includes 560 acres of hospitals, medical research facilities, laboratories, a biotech business incubator, universities, raw land development areas, and more than 40 health care–related facilities and is one of the largest urban medical districts in the United States. Dr. McKinney is former deputy commissioner of the Bureau of Public Health Preparedness and Emergency Response at the Chicago Department of Public Health, where she oversaw emergency preparedness efforts and coordinated those efforts within the broader spectrum of the City of Chicago’s Public Safety activities, in addition to overseeing the Department’s Division of Women and Children’s Health. Dr. McKinney previously served as senior advisor for public health and preparedness at the Tauri Group, where she provided strategic and analytical consulting services to the U.S. Department of Homeland Security’s (DHS’s) BioWatch Program. Dr. McKinney serves on numerous boards, committees, and advisory boards. Current board memberships include the Board of Directors for Susan G. Komen Chicago, Thresholds, and the African-American Legacy of the Chicago Community Trust. Dr. McKinney is co-chair of the National Academies’ Forum on Medical and Public Health Preparedness for Disasters and Emergencies and is a member of the Standing Committee on Health Threats Resilience. She also serves on the Science and Security Board for the Bulletin of the Atomic Scientists, the Board of Scientific Counselors for the Centers for Disease Control and Prevention, and the Office of Public Health Preparedness and Response, as well as the Federal Emergency Management Agency’s National Advisory Council. She has served as an Incident Commander for the Chicago Department of Public Health and was a member of Chicago’s Incident Management Team. She has been responsible for leading multiple emergency response efforts, including Chicago’s 2014–2015 Ebola response; the operational response to the 2009 H1N1 outbreak,
which was successful in vaccinating nearly 100,000 residents over a 6-week period; and the Chicago Department of Public Health’s participation in the 2012 NATO Summit response and the 2010 Haiti Earthquake response. Dr. McKinney has earned a reputation as an experienced, knowledgeable public health official with exceptional communication skills. She has also supported the U.S. Department of Defense’s Defense Threat Reduction Agency, providing subject-matter expertise in biological terrorism preparedness to the country of Poland. In academia, Dr. McKinney serves as instructor in the Division of Translational Policy and Leadership Development at the Harvard T.H. Chan School of Public Health and adjunct assistant professor of environmental and occupational health sciences at the University of Illinois at Chicago School of Public Health. Additionally, she serves as a mentor for the Biomedical Sciences Careers Project, also at Harvard University. She is author of the text Public Health Emergency Preparedness: Practical Solutions for the Real World (2018). Dr. McKinney received her doctorate from the University of Illinois at Chicago School of Public Health, with a focus on preparedness planning, leadership, and workforce development. She received a B.A. in biology from Brandeis University, where she was also a Howard Hughes Medical Institute fellow. She received her M.P.H. degree (health care administration) and certificates in managed care and health care administration from Benedictine University.
Jane P. Noyes, D.Phil., M.Sc., is professor of health and social services research and child health in the School of Health Sciences, Bangor University, United Kingdom. She is a clinical academic who completed health services research training with three competitive fellowships: Smith and Nephew 1-year predoctoral fellowship, UK Medical Research Council Health Services Research and Health of the Public 4-year doctoral fellowship, and UK Department of Health postdoctoral fellowship. She used these fellowship opportunities to develop and test methods for the new and emerging disciplines of mixed-method and qualitative evidence synthesis and the development, implementation, testing, and costing of complex interventions in complex health systems. Dr. Noyes is co-lead of the Wales National Centre for Population Health & Wellbeing Research and the Wales Kidney Research Unit. She is former co-chair and now member of the Cochrane Methods Executive, member of the Cochrane Scientific Committee, lead convenor of the Cochrane Qualitative and Implementation Methods Group, honorary visiting professor in child health at University College Dublin, and editor of the Journal of Advanced Nursing. She is a methodologist, systematic reviewer, and primary researcher with a particular interest in complex health and social interventions. Dr. Noyes is one of the founding members of the group that developed Grading of Recommendations Assessment, Development and Evaluation-Confidence in the Evidence from Reviews of Qualitative Research for assessing the confidence in findings of synthesized qualitative research. She also served as the methodologist on the World Health Organization team that developed the 2017 guideline for risk communication in public health emergencies. Dr. Noyes received her D.Phil. from York University in the United Kingdom.
Douglas K. Owens, M.D., M.S., is the Henry J. Kaiser Jr. Professor and director of the Center for Health Policy in the Freeman Spogli Institute for International Studies (FSI) and the Center for Primary Care and Outcomes Research (PCOR) in the Department of Medicine and School of Medicine at Stanford University. He is a general internist and associate director of the Center for Innovation to Implementation, a health services research center of excellence, at the U.S. Department of Veterans Affairs (VA) Palo Alto Health Care System. Dr. Owens is professor of medicine and, by courtesy, professor of health research and policy and professor of management science and engineering at Stanford University; he is also senior fellow at FSI. His research focuses on technology assessment, cost-effectiveness
analysis, evidence synthesis, and methods for clinical decision making and guideline development. Dr. Owens served for 4 years as chair of the Clinical Guidelines Committee of the American College of Physicians, which develops clinical guidelines used widely and published regularly in the Annals of Internal Medicine. He is chair of the U.S. Preventive Services Task Force. He also directed the Stanford–University of California, San Fransisco (UCSF), Evidence-based Practice Center and the Program on Clinical Decision Making and Guideline Development at PCOR. He co-directs two training programs in health services research: the VA Postdoctoral Fellowship in Health Services Research and the VA Postdoctoral Informatics Fellowship Program. Dr. Owens received a B.S. and an M.S. from Stanford University and an M.D. from UCSF. He completed a residency in internal medicine at the University of Pennsylvania and a fellowship in health research and policy at Stanford University. He is past president of the Society for Medical Decision Making. He received the VA Under Secretary’s Award for Outstanding Achievement in Health Services Research and the Eisenberg Award for Leadership in Medical Decision Making from the Society for Medical Decision Making. He was elected to the American Society for Clinical Investigation and the Association of American Physicians.
Sandra Quinn, Ph.D., is professor and chair in the Department of Family Science and senior associate director of the Maryland Center for Health Equity, School of Public Health, University of Maryland. She is currently co–principal investigator on a National Institute of General Medical Sciences/National Institutes of Health (NIH) grant on Supplementing Survey-Based Analyses of Group Vaccination Narratives and Behaviors Using Social Media. She was co–principal investigator on a National Institute on Minority Health and Health Disparities (NIMHD)/NIH Center of Excellence in Race, Ethnicity and Health Disparities Research. In recent years she was principal investigator on two U.S. Food and Drug Administration (FDA)funded studies: (1) Public Attitudes toward Medical Countermeasures, and (2) Investigating Factors Associated with Participation of Racial and Ethnic Minority Populations in FDA Regulated Research. Dr. Quinn was co–principal investigator of a Grand Opportunity grant from the Office of the Director, NIH and NIMHD, on Bioethics Research Infrastructure Initiative: Building Trust between Minorities and Researchers. As principal investigator of a Centers for Disease Control and Prevention (CDC)-funded study on Public Attitudes Toward H1N1 Influenza, she led two national surveys during the H1N1 influenza pandemic, becoming the first to examine public attitudes toward emergency use authorizations for drugs and vaccines and to test an empirical model of disparities in exposure, susceptibility, and access to care during a pandemic. She was also funded by CDC to study communication between postal workers and public health professionals during the anthrax attacks. Her research interests include vaccine acceptance in routine and emergency situations; the impact of social media on vaccine attitudes and behaviors; racial disparities in vaccine uptake; crisis and emergency risk communication, with a specific focus on minority populations; and engagement of minority and marginalized communities in research.
Paul Shekelle, M.D., Ph.D., M.P.H., spent 20 years as director of the Southern California Evidence-Based Practice Center site at RAND Corporation. He is consultant in health sciences at RAND; professor of medicine at the University of California, Los Angeles (UCLA), School of Medicine; and staff physician at the U.S. Department of Veterans Affairs Medical Center in West Los Angeles. He received his M.D. from Duke University, M.P.H. from UCLA, and Ph.D. from the UCLA School of Public Health. His scholarly interests are in the areas of evidence-based medicine, practice guidelines, and quality of care.
Andy Stergachis, Ph.D., B.Pharm., is professor of pharmacy and global health and adjunct professor of health services and epidemiology; associate dean, School of Pharmacy; and director of the Global Medicines Program, University of Washington (UW). He is the author of 165 peer-reviewed publications in such areas as drug safety, pharmaceutical outcomes, emergency preparedness and response, and clinical epidemiology and served as editor-in-chief of the Journal of the American Pharmacists Association. He is an elected member of the National Academy of Medicine. He is a fellow of the International Society for Pharmacoepidemiology and the American Pharmacists Association. He has been a member of the Drug Safety and Risk Management Advisory Committee for the U.S. Food and Drug Administration and was chair of the Malaria in Pregnancy Consortium Safety Working Group. He served as chair, Emergency Pharmaceutical Distribution Collaborative Group, Centers for Public Health Preparedness, Association of Schools of Public Health; was a member of the State of Washington Joint Advisory Committee for Public Health and Hospital Emergency Preparedness and Response; and served as coordinator for the Strategic National Stockpile for King County, Washington. Through his affiliation with the UW Northwest Center for Public Health Practice, he works with the public health community on workforce development and research in emergency preparedness. Dr. Stergachis has received numerous honors, including Pharmacist of the Year from the Washington State Pharmacy Association and the Martin Luther King, Jr. Community Volunteer Recognition Award from UW.
Mitch Stripling, M.P.A., is currently national director of emergency preparedness and response at the Planned Parenthood Federation of America. In this capacity, he works across the Planned Parenthood Federation to develop emergency preparedness programs that include planning, training, and exercises to prepare for likely threats, as well as building out an incident command system to deal with crises as they occur. He also coordinates contingency planning around such critical issues as the future of abortion access. Previously, Mr. Stripling oversaw the agency preparedness and response efforts at the New York City Department of Health and Mental Hygiene, including units for planning, training and exercises, risk analysis, intelligence, and evaluations. He coordinated citywide planning for the 2009 H1N1 pandemic and served as a planning section chief at the department for the responses to Hurricanes Irene and Sandy, the Ebola crisis, and the recent outbreaks of Legionella and Zika. His unit has developed nationally recognized threat response guides for 21 of the highest-risk scenarios that could impact New York City, a data- and consensus-driven risk assessment methodology, a principal scientific advisor model for public health incident command systems, and a strategic planning directive model for civilian use. Previously, he worked for the Florida Department of Health, where he helped plan and implement the responses to six federally declared disasters, including the 2004 record-breaking hurricane season and Florida’s response in southern Mississippi after Hurricane Katrina. During that time, he developed, rostered, and trained environmental health and other public health strike teams; built national training standards in collaboration with the Centers for Disease Control and Prevention; and focused on making communities more resilient in the face of environmental threats. Before working in public health, Mr. Stripling spent several years providing strategic consulting for Fortune 500 companies and government agencies. He began his career working at the United Nations Global Teaching and Learning Project on human rights issues.
Steven M. Teutsch, M.D., M.P.H., is an independent consultant; adjunct professor at the Fielding School of Public Health, University of California, Los Angeles; and senior fellow, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California. Until 2014 he was chief science officer, Los Angeles County Public Health, where
he continued his work on evidence-based public health and policy. Previously, he worked at Merck, where he was responsible for scientific leadership in developing evidence-based clinical management programs, conducting outcomes research studies, and improving outcomes measurement to enhance quality of care. Prior to joining Merck, he was director of the Division of Prevention Research and Analytic Methods (DPRAM) at the Centers for Disease Control and Prevention (CDC), where he was responsible for assessing the effectiveness, safety, and cost-effectiveness of disease and injury prevention strategies. DPRAM developed comparable methodology for studies of the effectiveness and economic impact of prevention programs, provided training in these methods, developed CDC’s capacity for conducting necessary studies, and provided technical assistance for conducting economic and decision analysis. The Division also evaluated the impact of interventions in urban areas, developed The Guide to Community Preventive Services, and provided support for CDC’s analytic methods. Dr. Teutsch has served as a member of the Community Preventive Services Task Force and the U.S. Preventive Services Task Force, as well as the Americas Health Information Community Personalized Health Care Workgroup and the Evaluation of Genomic Applications in Prevention and Practice Workgroup. He has chaired and served on a number of expert committees. Dr. Teutsch joined CDC in 1977, where he served in various capacities, focusing on parasitic diseases, kidney donation and kidney diseases, diabetes control, epidemiology, disease monitoring, and prevention effectiveness. He received his undergraduate degree in biochemical sciences at Harvard University, an M.P.H. in epidemiology from the University of North Carolina School of Public Health, and his M.D. from the Duke University School of Medicine. He completed his residency training in internal medicine at The Pennsylvania State University. He was certified by the American Board of Internal Medicine in 1977 and the American Board of Preventive Medicine in 1995, and is a fellow of the American College of Physicians and American College of Preventive Medicine. Dr. Teutsch has published more than 200 articles and 8 books in a broad range of fields in epidemiology, including parasitic diseases, diabetes, technology assessment, health services research, and surveillance.
Tener Goodwin Veenema, Ph.D., M.P.H., M.S., R.N., FAAN, is professor of nursing and public health at the Johns Hopkins University School of Nursing and the Johns Hopkins Bloomberg School of Public Health. As an internationally recognized expert in disaster nursing and public health emergency preparedness, she has served as senior scientist to the U.S. Department of Health and Human Services Office of Human Services Emergency Preparedness and Response, the U.S. Department of Homeland Security, the Federal Emergency Management Agency, and the Veterans Affairs Emergency Management Evaluation Center. An accomplished researcher, Dr. Veenema is a member of the American Red Cross National Scientific Advisory Board and is an elected fellow in the American Academy of Nursing; the National Academies of Practice; and the Royal College of Surgeons, Dublin, Ireland. She is editor of Disaster Nursing and Emergency Preparedness for Chemical, Biological and Radiological Terrorism and Other Hazards, 4th ed., the leading textbook in the field, and developer of Disaster Nursing, an innovative technology app. Dr. Veenema received master’s degrees in nursing administration (1992), pediatrics (1993), and public health (1999) and a Ph.D. in health services research and policy (2001) from the University of Rochester School of Medicine and Dentistry. She was awarded the Florence Nightingale Medal of Honor (International Red Crescent, 2013), the highest international award in nursing, for her professional service in disasters and public health emergencies and was the recipient of a Fulbright U.S. Scholar Award (2017). Dr. Veenema previously served on the National Academies’ Standing Committee for the Strategic National Stockpile. She currently serves as the 2017–2018 National Academy of Medicine Distinguished Nurse Scholar-in-Residence.
Matthew Wynia, M.D., M.P.H., is director of the Center for Bioethics and Humanities, University of Colorado, and professor of medicine at the University of Colorado School of Medicine. His training is in internal medicine, infectious diseases, public health, and health services research. From 1997 to 2015, Dr. Wynia worked at the American Medical Association (AMA), where he developed a research institute and training programs focused on bioethics, professionalism, and policy issues (the AMA Institute for Ethics) and founded the AMA’s Center for Patient Safety. He also practiced at the University of Chicago. His research has focused on understanding and improving the practical management of ethical issues in medicine and public health. He has led projects on a wide variety of issues related to ethics and professionalism. He has served on committees and expert panels and as a reviewer for the Health and Medicine Division of the National Academies, the Joint Commission, federal agencies, the Hastings Center, the American Board of Medical Specialties, and other organizations, and has delivered and held more than two dozen named lectures and visiting professorships nationally and internationally. Dr. Wynia is the author of more than 140 published articles, chapters, and essays. His work has been published in numerous leading medical and ethics journals, and he is a contributing editor for the American Journal of Bioethics. He is past president of the American Society for Bioethics and Humanities and has chaired the Ethics Forum of the American Public Health Association and the Ethics Committee of the Society for General Internal Medicine. He holds current board certifications in internal medicine and infectious diseases.
NATIONAL ACADEMY OF MEDICINE FELLOW
Mahshid Abir, M.D., M.Sc., was the National Academy of Medicine fellow supporting this study. Dr. Abir is an emergency physician and health services researcher with a joint appointment at the University of Michigan and RAND Corporation. She is director of the Acute Care Research Unit at the University of Michigan’s Institute for Healthcare Policy and Innovation. Her research evaluates strategies for improving acute care delivery in the United States along the care delivery continuum, including the prehospital, emergency, inpatient, ambulatory care, and community settings. Her work focuses on addressing policy-related issues pertaining to utilization, quality, efficiency, outcomes, and costs of acute care delivery in these settings.